Medications

Drugmakers agree to US govt price talks amid pushback

Major drugmakers have grudgingly agreed to negotiate on reducing prices for 10 medicines, the White House said Tuesday, a key element in President Joe Biden's push to lower health care costs ahead of the 2024 election.

Diseases, Conditions, Syndromes

Hospital COVID-19 burden impacted NSTEMI treatment, outcome

For patients with non-ST segment elevation myocardial infarction (NSTEMI), hospital COVID-19 burden was associated with worse outcomes and treatments but did not affect race and ethnicity-associated inequities, according ...

page 6 from 40